IGC Pharma Form 8-K Reporting - IGC Pharma, INC.

SEC

Filings

August 3, 2024

IGC Pharma Form 8-K Reporting

IGC Pharma 8-K 08-02-24 v1 Download

IGC Pharma, Inc. IGC on NYSE

Related Posts

IGC Pharma, Inc 8-K 10-10-25

October 10, 2025

IGC Pharma, Inc 8-K 10-01-25

October 1, 2025

IGC Pharma, Inc. 424B5 09-19-25

September 19, 2025

CEO Update

IGC Pharma Expands AI-Powered Drug Discovery In-Silico Pipeline

November 3, 2025

IGC Pharma Advances to Semi-Finals in the Alzheimer’s Insights AI Prize with “AHA: Agentic Harmonization Assistant”

October 22, 2025